MHRC Faculty Collaborative Research Grant Award
(updated August 2025)
Please download the Information and Application word document which contains all the relevant information to submit an application.
View previous recipients of this award.
Purpose
This MHRC grant is available to assist faculty in developing collaborative research projects.
Eligibility
All full-time active MHRC faculty members who currently supervise graduate students may apply.
Value
Applicants may request a maximum of up to $5000. In 2025, one such award will be given.
Deadline
Monday, November 17, 2025 at 4:00 pm.
Questions?
For more information, please contact Dr. Christopher Perry, MHRC Director at cperry@yorku.ca.
Previous Recipients of the MHRC Faculty Research Award:
|
Year |
Recipient |
Summary of Research |
|---|---|---|
|
2024 |
Dr. Michael Paris |
Acute Motor Unit Adaptations to High- load and Low- Load Resistance Exercise |
|
2023 |
Dr. Ola Adegoke & Dr. Tara Haas |
Can Exercise- Dependent Changes in Myokine Secretion Affect Breast Cancer Cell Growth |
|
2022 |
Dr. Andrea Josse & Dr. Ali Abdul- Sater |
Skeletal Muscle- Endothelial cell interactions in Cachexia The influence of dairy consumption on systemic and leukocyte inflammation |
|
2021 |
Dr. Anthony Scime & Dr. Tara Haas |
Muscle stem cell fates in a mouse model of peripheral artery disease |
|
2013 |
Dr. Ola Adegoke |
Amino acids are critical components of our diet, in that they are needed to make the different proteins that perform crucial functions in our bodies. Under some circumstances however, they have been implicated in insulin resistance. In this proposal, Dr. Adegoke will use funds provided by MHRC to examine the link between amino acids and insulin action in skeletal muscle. |
|
2012 |
Dr. Mazen Hamadeh |
Lou Gehrig’s disease is a neuromuscular disease that causes weakness and paralysis of muscle. Dr. Hamadeh is investigating the mechanisms that contribute to muscle dysfunction in this disease model. The award will be used to understand the role of vitamin D in mitigating the severity of the disease by manipulating vitamin D exposure at different levels from deficiency to adequacy to supraphysiological doses. |
|
2011 |
Dr. Michael Connor |
No Information |